Skip to content
Menu

Dr Reddy's Laboratories Q2 EPS $0.12 Misses $0.16 Estimate, Sales $905.000M Miss $980.650M Estimate

Benzinga Newsdesk 4 weeks ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.16 by 25 percent. This is a 36.84 percent decrease over earnings of $0.19 per share

Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.16 by 25 percent. This is a 36.84 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $905.000 million which missed the analyst consensus estimate of $980.650 million by 7.71 percent. This is a 8.77 percent decrease over sales of $992.000 million the same period last year.

Read at benzinga.com